Press Release
13 December 2023
港大醫學院首創「先縮後除」配以活肝移植 根治末期肝癌成全球先例 HKUMed sets global precedent: Successfully cures terminal liver cancer through combined 'Reduce and Remove' strategy with living donor liver transplantation |
03 November 2023
港大團隊研發嶄新「虛擬病人」問診應用程式 醫科訓練打破時間地域限制 促進國際醫學教育交流 HKU develops novel 'AI virtual patients' diagnostic application Breaking spatial and geographical barriers for medical training Revolutionising global medical education exchanges |
18 September 2023
醫學院發現手術出院後使用鴉片類藥物 會增加患者再次入院及死亡風險 HKUMed finds higher risks of hospital readmission and mortality among surgical patients who were discharged with opioids |
06 February 2023
港大醫學院與國際學者攜手 建立使用血漿 EB 病毒 DNA 於鼻咽癌診斷及治療的共識 HKUMed establishes international consensus recommendations on using plasma EBV DNA in clinical management of nasopharyngeal carcinoma |
11 January 2023
港大醫學院全球首創嶄新中期肝癌「先縮後除」綜合治療方案 HKUMed discovered a new treatment strategy for locally advanced liver cancer by ‘Reduce and Remove’ – a novel tri-modality therapy |
08 December 2022
港大醫學院全球首次發現肝癌免疫治療的新靶點 HKUMed discovers a novel immunotherapeutic target against hepatocellular carcinoma first time in the world |
19 July 2021
Many congratulations to Dr. Vincent Lui and Professor Paul Tam for the success of their 11th round RGC Theme-Based Research Scheme application! |
09 March 2021
港大醫學院發現常見於香港華人但罕被記載而與藥物有關的基因變異 HKUMed identifies rarely documented pharmacogenetic variants commonly found among Hong Kong Chinese, highlighting the potential for personalised medicine |
18 November 2020
港大醫學院發現β-澱粉樣蛋白異常沉積是膽道閉塞的新發病機制 HKUMed discovered beta-amyloid deposition to be a novel disease mechanism for Biliary Atresiaz |